Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Treace Medical Concepts
TMCI
$293M
| $590K | ﹤0.01% |
100,291
+47,228
| +89% | +$308K |
|
3602
Tyra Biosciences
TYRA
$1.49B
| $589K | ﹤0.01% |
61,555
+19,044
| +45% | +$181K |
|
3603
Village Super Market
VLGEA
$638M
| $589K | ﹤0.01% |
15,300
+6,534
| +75% | +$241K |
|
3604
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| $589K | ﹤0.01% |
19,561
| – | – |
|
3605
Health Catalyst
HCAT
$132M
| $588K | ﹤0.01% |
156,001
-109,352
| -41% | -$430K |
|
3606
Xperi
XPER
$320M
| $588K | ﹤0.01% |
74,277
+29,225
| +65% | +$220K |
|
3607
Home Bancorp
HBCP
$569M
| $586K | ﹤0.01% |
11,326
+4,273
| +61% | +$208K |
|
3608
ProShares VIX Short-Term Futures ETF
VIXY
$190M
| $586K | ﹤0.01% |
12,500
-2,000
| -14% | -$115K |
|
3609
Forum Energy Technologies
FET
$927M
| $586K | ﹤0.01% |
30,083
+7,389
| +33% | +$120K |
|
|
GRSD
3610
Grandstand Limited Ordinary Shares
GRSD
$67.3M
| $585K | ﹤0.01% |
49,224
+12,826
| +35% | +$158K |
|
3611
Frontier Group Holdings
ULCC
$1.57B
| $585K | ﹤0.01% |
161,177
+1,605
| +1% | +$5.88K |
|
|
CMRC
3612
Commerce.com Inc Series 1
CMRC
$184M
| $585K | ﹤0.01% |
116,960
+25,172
| +27% | +$130K |
|
3613
UWM Holdings
UWMC
$2.61B
| $584K | ﹤0.01% |
141,138
+49,063
| +53% | +$216K |
|
3614
Bioventus
BVS
$1.17B
| $583K | ﹤0.01% |
88,108
+41,032
| +87% | +$291K |
|
3615
Cricut
CRCT
$1.24B
| $582K | ﹤0.01% |
85,970
+26,198
| +44% | +$150K |
|
3616
Savara
SVRA
$1.08B
| $579K | ﹤0.01% |
253,828
+92,345
| +57% | +$251K |
|
3617
Boston Omaha
BOC
$431M
| $576K | ﹤0.01% |
41,046
+5,561
| +16% | +$81K |
|
3618
Direxion Daily Technology Bull 3x ETF
TECL
$6.47B
| $576K | ﹤0.01% |
6,150
-400
| -6% | -$26.4K |
|
3619
Plumas Bancorp
PLBC
$442M
| $575K | ﹤0.01% |
12,924
+6,680
| +107% | +$287K |
|
|
KALV
3620
CALL
DELISTED
KalVista Pharmaceuticals
KALV
| $574K | ﹤0.01% |
+50,800
| New | +$621K |
|
|
STRZ
3621
Starz Entertainment Corp
STRZ
$479M
| $574K | ﹤0.01% |
+35,711
| New | +$566K |
|
3622
Bridgewater Bancshares
BWB
$620M
| $572K | ﹤0.01% |
35,935
+15,452
| +75% | +$226K |
|
3623
Spire Global
SPIR
$540M
| $571K | ﹤0.01% |
47,942
+23,688
| +98% | +$239K |
|
3624
Viant Technology
DSP
$274M
| $570K | ﹤0.01% |
43,117
+12,146
| +39% | +$166K |
|
3625
Vishay Precision Group
VPG
$908M
| $568K | ﹤0.01% |
20,212
+7,003
| +53% | +$173K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.